Form 4: Orgenesis Inc. Director Ashish Nanda Acquires Stock Options

Director Ashish Nanda of Orgenesis Inc. was granted 1,835 stock options under the company's 2017 Equity Incentive Plan.

Summary

• Ashish Nanda, a director at Orgenesis Inc., was granted 1,835 stock options on December 12, 2024.
• These options were awarded under the company's 2017 Equity Incentive Plan.
• The options have an exercise price of $0.98 per share.
• The options vest one year from the grant date, on December 12, 2025, subject to continued service on the Board of Directors.
• The options expire on December 12, 2034.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of stock options to a director, which is generally viewed as a positive incentive. There is no indication of any negative sentiment.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting period encourages continued service and commitment from the director.

Future Outlook

The director's continued service is required for the options to vest.

Industry Context

Stock option grants are a common form of compensation for directors and executives in publicly traded companies, aligning their interests with shareholders.

Comparison to Industry Standards

• Stock option grants are a standard practice for compensating board members in publicly traded companies.
• The vesting period of one year is typical for such grants, encouraging long-term commitment.
• The exercise price of $0.98 is a common practice, often set at or near the market price at the time of the grant.

Stakeholder Impact

• The stock option grant aligns the director's interests with those of the shareholders, potentially leading to better performance and value creation.

Key Dates

Keywords

stock options, equity incentive plan, director, Orgenesis Inc., insider trading, beneficial ownership, executive compensation